<DOC>
	<DOCNO>NCT01121497</DOCNO>
	<brief_summary>The purpose study determine whether administration physostigmine combination sedation colonoscopy minimize cognitive decline time hospital discharge</brief_summary>
	<brief_title>The Effect Physostigmine Cognitive Functioning Immediate Period After Sedation Colonoscopy</brief_title>
	<detailed_description>Physostigmine , tertiary cholinesterase inhibitor , prevents breakdown ACh inhibit enzyme acetylcholinesterase ( AChE ) , cross blood-brain barrier ( BBB ) , elevate brain ACh level . Physostigmine show improve attention , performance work memory . It also show produce analgesia follow systemic central administration . Patients undergo colonoscopy sedation propofol fentanyl show cognitive decline immediate period follow procedure . In study , half patient receive physostigmine combination sedation , cognitive functioning time hospital discharge assess standard neuropsychological test , compare patient without physostigmine .</detailed_description>
	<mesh_term>Physostigmine</mesh_term>
	<criteria>Over18 year old ASA IIII Fluency Hebrew , Russian , Arabic Absence serious hear vision impairment History head trauma , neurological disease , alcoholism , drug abuse , consumption psychotropic drug antidepressant Heart failure ( NYHA &gt; 3 ) Liver failure Respiratory problem ( asthma , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Sedation</keyword>
	<keyword>Cognitive decline</keyword>
	<keyword>Physostigmine</keyword>
	<keyword>Colonoscopy</keyword>
</DOC>